Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Welte

Showing results (221-230 of 237) with videos related to

Pageof 24
Sort By:
Investigational New Drugs|September 1, 1988
A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinomaP B Chapman, J E Kolitz, T B Hakes, et al.
Haematology and Blood Transfusion|January 1, 1983
Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromesK Welte, S Venuta, C Y Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigenS J Forman, J A Zaia, B R Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approachC Beger, L N Pierce, M Kruger, et al.
Bone Marrow Transplantation|December 8, 2004
Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler)L Grigull, A Beilken, M Schrappe, et al.
Blood|September 26, 2000
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropeniaD C Dale, R E Person, A A Bolyard, et al.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Bone Marrow Transplantation|September 5, 2007
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaB Meissner, A Borkhardt, D Dilloo, et al.
Leukemia|January 1, 1997
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropeniaF Dong, D C Dale, M A Bonilla, et al.
Blood|July 11, 2000
Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapyM H Freedman, M A Bonilla, C Fier, et al.
Pageof 24

Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
Investigational New Drugs|September 1, 1988
A phase I trial of intraperitoneal recombinant interleukin 2 in patients with ovarian carcinomaP B Chapman, J E Kolitz, T B Hakes, et al.
Haematology and Blood Transfusion|January 1, 1983
Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromesK Welte, S Venuta, C Y Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigenS J Forman, J A Zaia, B R Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approachC Beger, L N Pierce, M Kruger, et al.
Bone Marrow Transplantation|December 8, 2004
Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler)L Grigull, A Beilken, M Schrappe, et al.
Blood|September 26, 2000
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropeniaD C Dale, R E Person, A A Bolyard, et al.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Bone Marrow Transplantation|September 5, 2007
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaB Meissner, A Borkhardt, D Dilloo, et al.
Leukemia|January 1, 1997
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropeniaF Dong, D C Dale, M A Bonilla, et al.
Blood|July 11, 2000
Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapyM H Freedman, M A Bonilla, C Fier, et al.
Pageof 24